ObjectiveTo evaluate the efficacy and complications of donor lymphocyte infusion (DLI) following nonmyeloablative stem cell transplantation(NSCT)for the patients with hematologic diseases.

• 研究非清髓性造血干细胞移植治疗血液病和供者淋巴细胞输注的疗效及并发症。